IQVIA
IQVIA, Inc. is a prominent provider of advanced analytics, technology solutions, and contract research services tailored for the healthcare industry. The company, formed from the merger of Quintiles and IMS Health in 2016, specializes in collecting, organizing, and analyzing extensive healthcare data, including sales, prescriptions, medical claims, and electronic health records. Its offerings include cloud applications for business analytics, real-world evidence solutions to assess treatment value, and clinical solutions to support the design and execution of clinical trials. IQVIA serves a diverse clientele that includes pharmaceutical, consumer health, and medical device manufacturers, as well as providers, payers, government agencies, and researchers. By leveraging its big data resources and domain expertise, IQVIA aims to enhance healthcare outcomes through informed decision-making and improved treatment development processes. The company is based in Danbury, Connecticut.
RxWare is a company that specializes in developing a mobile patient platform designed to optimize patient services for specialty pharmaceuticals. Founded in 2013 and headquartered in Wilmington, Delaware, RxWare's mobile intelligence platform provides a comprehensive technology framework that personalizes patient services. Its application serves individuals with diabetes, offering resources on symptoms, management, and diet to help users lower their A1C levels. By integrating behavioral insights with community features and user functionality, RxWare enables patient programs to effectively learn, adapt, and respond to the unique health needs and circumstances of patients, thereby enhancing their overall healthcare experience.
BC Platforms specializes in genomic data management solutions aimed at tackling significant healthcare challenges. The company offers a robust data management platform that facilitates the integration, secure analysis, and interpretation of molecular and clinical data. By combining genomics with IT, BC Platforms empowers health organizations to make informed decisions in drug development and delivery. Their systematic and standardized approach allows for efficient handling of complex health data, ultimately supporting improved outcomes in healthcare.
Octopus.Health is a patient engagement platform for proactive population health. The company technology creates a Healthcare Personal Assistant that supports millions of patients and tailors a personalized proactive healthcare plan for each patient based on advanced machine learning algorithms. Octopus.Health leverages AI and Machine Learning to revolutionize how patient adherence is being managed today. It was founded in 2017 and is based in Tel Aviv, Israel.
Belong.Life, founded in 2015 by Eliran Malki, Irad Deutsch, and Ohad Rubin, focuses on enhancing the cancer care experience through its innovative platform. The company offers Belong – Beating Cancer Together, a free patient navigation app designed for cancer patients and their support networks, allowing them to effectively manage their treatment journeys and improve their quality of life. Belong.Life is also developing PEP, an end-to-end solution for healthcare organizations that includes customizable patient engagement tools and navigation services. The platform utilizes proprietary artificial intelligence and machine learning algorithms to streamline patient navigation, deliver treatment templates and reminders, and provide insights into patient journeys and treatment strategies. This comprehensive approach aims to improve patient engagement, education, and compliance in the fight against cancer.
Linguamatics is a software company providing high performance natural language processing (NLP) based text mining software.
The software enables the rapid extraction of business critical facts and relationships from large document collections.
Linguamatics' text mining software can be used for business and competitive intelligence, life sciences research, and mining social media such as twitter.
Beijing Naxions Technology Co., Ltd. is a healthcare-focused company that specializes in providing digital marketing services tailored for the pharmaceutical industry. Founded in 2014 and headquartered in Chaoyang District, China, with additional offices in Shanghai, Naxions has developed a software-as-a-service (SaaS) platform designed to enhance pharmaceutical sales management. The platform offers a range of services, including data capture, cleaning, and analysis, alongside features for content sharing and project management. By leveraging internet technology, Naxions aims to support pharmaceutical enterprises in developing their brand image and increasing market awareness through real-time data analysis and visualization.
Advanced Health Media, LLC specializes in providing software and services designed to manage healthcare professional engagements, primarily for the pharmaceutical and life sciences industries. Its offerings include CentrisDirect for managing the HCP engagement ecosystem, CentrisEngage for meeting and engagement solutions, CentrisConnect as a customer-centric portal for data management, and CentrisIQ, which provides business intelligence and analytics based on data from CentrisDirect. The company also offers CentrisServices for meeting and engagement support and CentrisExchange for integration with third-party solutions. Established in 1999 and headquartered in New Providence, New Jersey, Advanced Health Media operates globally with additional offices in Norfolk, Virginia; Manila, Philippines; and London, United Kingdom. The company is recognized for managing over 150,000 events annually, having completed more than one million events since 2005, and is dedicated to investing in innovative solutions that enhance client experience and ensure compliance.
ObvioHealth is a clinical research platform focused on enhancing the efficiency of the clinical trial process. By leveraging advanced technology, the platform enables sponsors to obtain superior data while providing participants with a more convenient trial experience, allowing them to engage in virtual clinical trials from their homes. Supported by SPRIM, a global leader in health-centric innovation with extensive expertise in medical and life sciences, ObvioHealth benefits from a strong foundation in digital capabilities and regulatory knowledge. This collaboration aims to drive disruptive innovations and facilitate new market entries, ultimately striving to deliver tangible results in the clinical research landscape.
COTA, Inc. is a Boston-based company that specializes in developing a platform designed to provide data and insights related to cancer patients, aimed at guiding treatment decisions. Founded in 2011 by a team of doctors, engineers, and data scientists, COTA utilizes proprietary technology and advanced analytics to transform fragmented electronic health record (EHR) data into cohesive, research-grade information. This platform supports oncology practices and cancer centers by identifying variations in care, thus enabling the design of effective treatment programs and payment models. COTA's solutions serve a diverse range of stakeholders, including healthcare providers, payers, life sciences companies, and the FDA, ultimately striving to enhance patient outcomes and reduce healthcare costs associated with cancer care.
DrugDev is a family of technology-driven solutions that help doctors, sponsors, and CROs do more clinical trials together. DrugDev brings together the largest online network of clinical trial sites, the leading investigator identification and start-up platform, the industry’s best trial optimization system, and the leading grants payment capabilities to transform the way drug developers find, engage and pay doctors to run clinical trials. DrugDev is also the host of the Investigator Databank, a global collaboration between Lilly, Merck, Pfizer, Janssen, Novartis and DrugDev (with more joining soon) to help increase clinical trial opportunities and reduce the administrative workload for over 200,000 clinical trial doctors worldwide.
Pilgrim Software is a world-leading provider of Enterprise Risk, Compliance and Quality Management software solutions for highly regulated industries. Pilgrim has pioneered effective, integrated software solutions for the Life Science industries, as well as manufacturers in the automotive, aerospace and defense, and other non-FDA regulated industries. Pilgrim’s reputation for excellence in innovation has attracted an impressive portfolio of global customers. More than a half-million end-users employ Pilgrim products every day to meet the diverse challenges of the world’s highly competitive marketplace. Pilgrim’s fully Web-based, integrated solutions help businesses centrally manage domestic and international operations to ensure product safety and compliance, reduce manufacturing costs and improve customer satisfaction.
STI Group Inc has acquired software development and managed network support services business.
Aileron Solutions, LLC specializes in providing data and analytics services tailored for pharmaceutical and medical device manufacturers. Founded in 2009 and located in Conshohocken, Pennsylvania, the company offers a range of data products, including precision targeting claims data, physician affiliations data, and physician reference data. These products are designed to enhance the understanding of physician networks and patient flow. Aileron Solutions also delivers data management services, such as deduplication, record resolution, and data validation, alongside analytics services that focus on physician influence and network affiliations. The company's offerings are aimed at improving decision-making and operational efficiency within the healthcare industry.
Novella Clinical is a specialized contract research organization (CRO) that caters to the unique requirements of small to mid-sized oncology companies, as well as those in the medical device and diagnostics sectors. The company offers a comprehensive range of clinical trial management services, spanning from preclinical stages to post-approval. Novella has developed a flexible business model and possesses global capabilities, with a team of therapeutically-aligned professionals who are well-versed in the specific needs of oncology and medical device trials. This targeted approach allows Novella to effectively support its clients in navigating the complexities of clinical research.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.